Free Trial
NYSE:WST

West Pharmaceutical Services (WST) Stock Price, News & Analysis

$328.59
-5.70 (-1.71%)
(As of 05/23/2024 ET)
Today's Range
$328.01
$335.29
50-Day Range
$328.59
$395.94
52-Week Range
$310.42
$415.73
Volume
459,630 shs
Average Volume
580,021 shs
Market Capitalization
$23.93 billion
P/E Ratio
43.35
Dividend Yield
0.24%
Price Target
$435.20

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
32.4% Upside
$435.20 Price Target
Short Interest
Healthy
1.44% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
0.72mentions of West Pharmaceutical Services in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$48.29 M Sold Last Quarter
Proj. Earnings Growth
18.04%
From $7.76 to $9.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.95 out of 5 stars

Medical Sector

12th out of 915 stocks

Surgical & Medical Instruments Industry

2nd out of 95 stocks

WST stock logo

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

WST Stock News Headlines

West to Host First-Quarter 2024 Conference Call
WST Apr 2024 450.000 call
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/1 Dividend
4/23/2024
Last Earnings
4/25/2024
Dividend Payable
5/01/2024
Today
5/24/2024
Next Earnings (Estimated)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
CUSIP
95530610
Employees
10,600
Year Founded
1923

Price Target and Rating

Average Stock Price Target
$435.20
High Stock Price Target
$536.00
Low Stock Price Target
$375.00
Potential Upside/Downside
+32.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$593.40 million
Pretax Margin
22.79%

Debt

Sales & Book Value

Annual Sales
$2.95 billion
Cash Flow
$9.92 per share
Book Value
$36.80 per share

Miscellaneous

Free Float
72,457,000
Market Cap
$23.93 billion
Optionable
Optionable
Beta
1.05

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

WST Stock Analysis - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WST shares.
View WST analyst ratings
or view top-rated stocks.

What is West Pharmaceutical Services' stock price target for 2024?

5 brokers have issued 12 month price objectives for West Pharmaceutical Services' stock. Their WST share price targets range from $375.00 to $536.00. On average, they predict the company's share price to reach $435.20 in the next twelve months. This suggests a possible upside of 32.4% from the stock's current price.
View analysts price targets for WST
or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2024?

West Pharmaceutical Services' stock was trading at $352.12 at the beginning of 2024. Since then, WST stock has decreased by 6.7% and is now trading at $328.59.
View the best growth stocks for 2024 here
.

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our WST earnings forecast
.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) posted its earnings results on Thursday, April, 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.29 by $0.27. The medical instruments supplier earned $695.40 million during the quarter, compared to analysts' expectations of $670.62 million. West Pharmaceutical Services had a trailing twelve-month return on equity of 20.57% and a net margin of 19.42%. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.98 earnings per share.
Read the conference call transcript
.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, April 25th. Investors of record on Wednesday, July 31st will be given a dividend of $0.20 per share on Wednesday, August 7th. This represents a $0.80 annualized dividend and a yield of 0.24%. The ex-dividend date is Wednesday, July 31st.
Read our dividend analysis for WST
.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.24%. The company has been increasing its dividend for 31 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 10.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2024 earnings guidance on Thursday, April, 25th. The company provided earnings per share (EPS) guidance of 7.630-7.880 for the period, compared to the consensus estimate of 7.620. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.0 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (12.27%), Bank of New York Mellon Corp (4.50%), Price T Rowe Associates Inc. MD (2.79%), Bamco Inc. NY (1.22%), TD Asset Management Inc (0.85%) and Findlay Park Partners LLP (0.82%). Insiders that own company stock include Annette F Favorite, Bernard Birkett, Chad Winters, Charles Witherspoon, Cindy Reiss-Clark, Eric Mark Green, Quintin J Lai, Silji Abraham and Thomas W Hofmann.
View institutional ownership trends
.

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
This page (NYSE:WST) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners